Corient Capital Partners’s Aptiv APTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$563K Buy
6,321
+55
+0.9% +$5.28K 0.04% 313
2022
Q2
$558K Buy
6,266
+1,634
+35% +$167K 0.04% 324
2022
Q1
$554K Sell
4,632
-7,667
-62% -$1.02M 0.04% 362
2021
Q4
$2.03M Buy
12,299
+7,813
+174% +$1.3M 0.13% 146
2021
Q3
$668K Sell
4,486
-100
-2% -$15.6K 0.05% 295
2021
Q2
$722K Buy
4,586
+385
+9% +$56.4K 0.05% 279
2021
Q1
$580K Buy
4,201
+609
+17% +$88.6K 0.05% 287
2020
Q4
$468K Buy
3,592
+171
+5% +$19K 0.05% 283
2020
Q3
$314K Buy
3,421
+33
+1% +$2.77K 0.04% 333
2020
Q2
$264K Buy
+3,388
New +$233K 0.03% 370
2018
Q1
Sell
-27,160
Closed -$2.3M 252
2017
Q4
$2.3M Buy
27,160
+811
+3% +$77.2K 0.39% 77
2017
Q3
$2.59M Sell
26,349
-2,039
-7% -$192K 0.49% 53
2017
Q2
$2.49M Sell
28,388
-6,556
-19% -$547K 0.38% 75
2017
Q1
$2.81M Buy
34,944
+1,985
+6% +$149K 0.44% 57
2016
Q4
$2.22M Buy
+32,959
New +$2.21M 0.39% 68

Other funds holding APTV

Corient Capital Partners's APTV Position: Q3 2022 in Review

Corient Capital Partners increased its Aptiv (APTV) stake by 0.88% in Q3 2022, buying an estimated $5.28K and bringing the position to 6,321 shares worth $563K. The position accounts for 0.04% of the portfolio, ranked #313.

Corient Capital Partners first reported a position in APTV in Q4 2016 and has held it in 15 quarters since. The position peaked at $2.81M in Q1 2017. 680 funds tracked by Wall St. Rank hold APTV as of Q3 2022.

  • Corient Capital Partners held 6,321 shares of Aptiv worth $563K as of Q3 2022.
  • Corient Capital Partners bought 55 Aptiv shares in Q3 2022, an estimated $5.28K.
  • Aptiv made up 0.04% of Corient Capital Partners's portfolio in Q3 2022, its #313 holding.
  • Corient Capital Partners first reported a position in Aptiv in Q4 2016 and has held it in 15 quarters since.
  • Corient Capital Partners's Aptiv position peaked at $2.81M in Q1 2017.
  • 680 funds tracked by Wall St. Rank held Aptiv as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.